Shenzhen YHLO Biotech Co., Ltd. (SHA:688575)
9.11
+0.35 (4.00%)
Jul 1, 2026, 3:00 PM CST
Shenzhen YHLO Biotech Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Shenzhen YHLO Biotech stock has a consensus rating of "Strong Buy" and an average price target of ¥16.98. The average 1-year stock price forecast is 86.39% higher than the current stock price, while the lowest is ¥15.00 (+64.65%) and the highest is ¥19.24 (+111.20%).
Price Target: ¥16.98 (+86.39%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Shenzhen YHLO Biotech stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 4 | 4 | 4 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 6 | 6 | 6 | 5 | 5 |
Financial Forecast
Revenue This Year
1.96B
from 1.81B
Increased by 8.25%
Revenue Next Year
2.44B
from 1.96B
Increased by 24.41%
EPS This Year
n/a
EPS Next Year
n/a
Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.0B | ||
| Avg | 2.0B | ||
| Low | 2.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 8.2% | ||
| Avg | 8.2% | ||
| Low | 8.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |
EPS Growth
| EPS Growth | 2027 | 2028 |
|---|---|---|
| High | - | |
| Avg | - | |
| Low | - |